Literature DB >> 7011529

Graves' ophthalmopathy.

J R Wall, J Henderson, C R Strakosch, D M Joyner.   

Abstract

Graves' ophthalmopathy usually occurs in association with hyperthyroidism. Its occasional occurrence in the absence of thyroid disease suggests, however, that it may be a separate autoimmune disorder. While the evidence supporting an autoimmune pathogenesis is considerable for the ophthalmopathy, it is not so impressive as that for Graves' hyperthyroidism: orbital antibodies have not been convincingly demonstrated and autoantigens have not been identified. On the other hand, in patients with Graves' ophthalmopathy the orbital tissues and eye muscle membranes are infiltrated with lymphoid cells and show evidence of cell-mediated immune reactions. Although there is some evidence that binding of thyroid stimulating hormone fragments and thyroglobulin-antithyroglobulin immune complexes to eye muscle membranes may be important in the pathogenesis of the ophthalmopathy, this needs to be confirmed. The mechanism for the association of hyperthyroidism and ophthalmopathy is unknown, but the association likely reflects an influence of thyroid hormones on the immune system. In view of the autoimmune pathogenesis the logical treatment of Graves' ophthalmopathy appears to be immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011529      PMCID: PMC1705349     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  81 in total

Review 1.  REVIEW: PATHOGENESIS OF GRAVES' DISEASE: ROLE OF THE LONG-ACTING THYROID STIMULATOR.

Authors:  J M MCKENZIE
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  The thyroid-stimulating hormone of the anterior pituitary as distinct from the exophthalmos-producing substance.

Authors:  B M DOBYNS; S L STEELMAN
Journal:  Endocrinology       Date:  1953-06       Impact factor: 4.736

Review 3.  The pathogenesis of endocrine exophthalmos: a short review.

Authors:  D Doniach
Journal:  Proc R Soc Med       Date:  1977-10

4.  Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane.

Authors:  J Konishi; M M Herman; J P Kriss
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

5.  Detection of antibodies which can cooperate with lymphocytes.

Authors:  O Fakhri; J R Hobbs
Journal:  Lancet       Date:  1972-08-26       Impact factor: 79.321

6.  Immunosuppressive therapy for the eye changes of Graves' disease.

Authors:  G N Burrow; M S Mitchell; R O Howard; L B Morrow
Journal:  J Clin Endocrinol Metab       Date:  1970-09       Impact factor: 5.958

7.  Large doses of radioiodine in the treatment of thyrotoxicosis.

Authors:  S H Ingbar
Journal:  N Engl J Med       Date:  1968-12-19       Impact factor: 91.245

8.  Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle.

Authors:  B R Mullin; R E Levinson; A Friedman; D E Henson; R J Winand; L D Kohn
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

9.  Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes.

Authors:  D Bolonkin; R L Tate; J H Luber; L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

10.  Ophthalmopathy associated with primary hypothyroidism.

Authors:  B E Brownlie; O A Newton; S P Singh
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08
View more
  8 in total

1.  Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.

Authors:  P A Easton; J R Wall
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

2.  Squamous cell carcinoma of the eyelid masquerading as 'malignant' ophthalmopathy of Graves's disease.

Authors:  H C Ford; J W Delahunt; C A Teague
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

3.  Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.

Authors:  H Tamaki; N Amino; Y Iwatani; K Miyai
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

Review 4.  Thyroid associated ophthalmopathy - a review.

Authors:  Ps Mallika; Ak Tan; S Aziz; Sar Syed Alwi; Ms Chong; R Vanitha; G Intan
Journal:  Malays Fam Physician       Date:  2009-04-30

5.  Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.

Authors:  T Kuroki; J Ruf; L Whelan; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.

Authors:  P G Walfish; I S Gottesman; J L Baxter
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

7.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

8.  A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.

Authors:  Roy Moncayo; Helga Moncayo
Journal:  BMC Musculoskelet Disord       Date:  2007-02-23       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.